William S. Smith Appointed as President of ALR Technologies
RICHMOND, VA -- (Marketwired) -- 04/18/14 -- ALR Technologies, Inc.
(OTCBB: ALRT) announces today that William S. Smith has been
appointed President of the Company, effective May 19, 2014. Mr.
Lawrence Weinstein, who served as President & COO of ALR Technologies
since 2010, expressed a wish to pursue other activities and will
remain as a consultant.
Mr. Smith has served as Director, Commercial Strategies and External
Affairs at ALR Technologies since February 2013. Prior to joining
ALRT, he worked at senior levels in the private sector and in
government for more than two decades. He served as Managing Director
at NSI, a Washington-based consulting firm, whose clients include
major pharmaceutical and biotechnology companies. He spent ten years
at Pfizer Inc., where he was Vice President for U.S. Public Affairs
and Policy. In that role, Smith was the lead advisor on U.S. policy
issues to Pfizer's major commercial businesses in the United States.
Smith also ran Pfizer's state government affairs group, one of the
largest such groups in corporate America. Mr. Smith previously worked
in government, where he was on the staff of two Governors in
Massachusetts, was a leadership aide to the Republican Leadership in
the U.S. House of Representatives, and was a senior aide in the White
House Office of National Drug Control Policy under President George
"Larry's experience and knowledge were integral in ALRT receiving
regulatory approvals and putting management systems in place during
the development stage. He was the ideal President for our company
during the critical start-up and will contribute to the company on an
ongoing basis," said Sidney Chan, Chief Executive Officer of ALR
Technologies. "I am pleased to announce that Bill Smith has agreed to
become President. Bill's experience and skills will be invaluable for
the commercialization phase of the company that we are now entering."
About ALR Technologies
ALR Technologies is a medical device company providing remote
monitoring and care facilitation for patients with chronic diseases.
ALRT has developed the FDA-cleared Health-e-Connect system which
uploads the data from blood glucose meters onto a secure website
where clinicians and others can better monitor and coordinate the
care of these patients. The platform will be expanded to cover
patients with other chronic diseases. More information on ALR
Technologies and its products can be found at http://www.alrt.com.
This release contains certain "forward-looking statements" relating
to ALR Technologies' business, and these statements reflect the
current views of ALR Technologies with respect to future events and
are subject to certain risks, uncertainties and assumptions. When
used, the words "estimate", "expect", "anticipate", "believe" and
similar expressions are intended to identify such forward-looking
statements. There are many factors that could cause the actual
results, performance or achievements of ALR Technologies and its
products to be materially different from any future results,
performances or achievements that may be expressed or implied by such
forward-looking statements. Further management discussions of risks
and uncertainties can be found in the company's quarterly filings
with the Securities and Exchange Commission.
Press spacebar to pause and continue. Press esc to stop.